Financials

  • Market Capitalization 283.47 M
  • Employee 48
  • Founded 2015
  • CEO N/A
  • Website www.alxoncology.com
  • Headquarter Delaware, United States
  • FIGI BBG00VR8SDG8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.59
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3351
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.85 USD-0.26%0.00%+4.34%-42.62%293.74 M USD
3365
AVXL
Anavex Life Sciences Corp. - Common Stock
3.13 USD-3.40%-1.57%+22.27%-65.98%290.06 M USD
3379
TRDA
Entrada Therapeutics, Inc. - Common Stock
7.27 USD+3.86%-4.84%+25.78%+4.30%283.07 M USD
3383
SRZN
Surrozen, Inc. - Common Stock
24.01 USD+1.27%+1.18%+22.63%+107.16%282.20 M USD

Frequently asked questions about ALX Oncology Holdings Inc. Common Stock

What is the ALX Oncology Holdings Inc. Common Stock stock price today?

The current price of ALX Oncology Holdings Inc. Common Stock (ALXO) is 2.05. Over the past 24 hours, the stock has changed by +3.54%. Follow the ALXO chart for real-time price dynamics.

What is the stock ticker of ALX Oncology Holdings Inc. Common Stock?

ALX Oncology Holdings Inc. Common Stock trades under the ticker ALXO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is ALX Oncology Holdings Inc. Common Stock stock going up?

ALXO has changed by +1.99% over the last week, +4.06% over the last month, and +79.82% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of ALX Oncology Holdings Inc. Common Stock?

ALX Oncology Holdings Inc. Common Stock currently has a market capitalization of 283.47 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were ALX Oncology Holdings Inc. Common Stock earnings last quarter?

Last quarter, ALX Oncology Holdings Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was ALX Oncology Holdings Inc. Common Stock revenue for the last quarter?

ALX Oncology Holdings Inc. Common Stock reported quarterly revenue of -904 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was ALX Oncology Holdings Inc. Common Stock net income for the last quarter?

ALX Oncology Holdings Inc. Common Stock reported net income of -17.97 M for the last quarter. The previous quarter showed -17.93 M, which means net income changed by -0.25%.

How many employees does ALX Oncology Holdings Inc. Common Stock have?

As of the latest available data, ALX Oncology Holdings Inc. Common Stock has 48 employees. Workforce size can provide additional context about the company's scale and operations.

What is ALX Oncology Holdings Inc. Common Stock EBITDA?

ALX Oncology Holdings Inc. Common Stock EBITDA is -18.85 M, and its EBITDA margin is 2 085.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy ALX Oncology Holdings Inc. Common Stock stock?

You can buy ALX Oncology Holdings Inc. Common Stock (ALXO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in ALX Oncology Holdings Inc. Common Stock stock?

Investing in ALX Oncology Holdings Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALXO chart and related analysis on metatrader.com as part of your research.

News